"Generex has also focused on special groups – ch

"Generex has also focused on special groups – children and pregnant women. Moscato thinks that his vaccine, which is guided by the four basic blood types, will be effective in 98% of all people on the planet. Additionally, Moscato reports, "The in vivo testing currently in progress is turning out to be much, much better than we anticipated.""

That is encouraging. Tell us about it.

Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.